FibroGen, Inc

FibroGen, Inc is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. FibroGen, Inc is not very popular among insiders. FibroGen, Inc is a mediocre stock to choose.

FibroGen, Inc. engages in the discovery, development, and commercialization of therapeutics. It focu...

News

FibroGen Executives Depart Amid U.S. Operations Overhaul

TipRanks Financial Blog The latest update is out from FibroGen ( ($FGEN) ). FibroGen, Inc. is streamlining its U.S. operations with a significant cost reduction strategy, leading to the te...\n more…

FibroGen CFO, CMO to leave company by year's end

Seeking Alpha - Healthcare FibroGen CFO, CMO to leave company by year's end...\n more…

FibroGen CFO, Chief Medical Officer to leave

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

FibroGen to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Globe Newswire SAN FRANCISCO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 26th Annual Global...\n more…

The Market Doesn't Like What It Sees From FibroGen, Inc.'s (NASDAQ:FGEN) Revenues Yet As Shares Tumble 65%

Simply Wall St FibroGen, Inc. ( NASDAQ:FGEN ) shareholders that were waiting for something to happen have been dealt a blow with a 65...\n more…

FibroGen, Inc. (FGEN) Q2 2024 Earnings Call Transcript

Seeking Alpha: Transcripts FibroGen, Inc. (FGEN) Q2 2024 Earnings Call Transcript...\n more…